Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits - PubMed (original) (raw)

Review

Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits

T G Terrell et al. Int Rev Exp Pathol. 1993.

Abstract

The systemic administration of high doses of rHuTGF-beta 1 to rats produced a spectrum of lesions in multiple target tissues, including liver, bone, kidney, heart, thymus, pancreas, stomach, cecum, at the injection vein, and in skeletal muscle at the site of anesthetic injection. The majority of these lesions can be attributed to known biological activities of TGF-beta 1. High-dose dermal application resulted in local effects at the wound sites without systemic toxicity.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources